“With Helix, we get clinical-grade genomic data and a turnkey platform to enable clinical and research insights, giving us the flexibility to build the initiative that is right for our patients, providers, and researchers. They are fantastic partners in an ambitious population health study.”
Joseph Grzymski, Ph.D.
Principal Investigator, Healthy Nevada Project
Chief Scientific Officer, Renown Health
Health system leaders today are constantly balancing competing priorities and searching for efficient solutions to achieve ambitious strategic goals:
Increase provider satisfaction
cost of care
Population Genomics with Helix
Driven by the Sequence Once, Query OftenTM model, population genomics with Helix allows health systems to uncover genetic risk more efficiently and utilize genetic insights at the point-of-care. Leading health systems have seen these programs improve care, address health inequities and engage patients & providers, all while reducing costs.
Improve clinical outcomes through earlier and more appropriate monitoring & treatment
Decrease costs from early identification and intervention for at-risk patients
Create a roadmap for innovation with accelerated genetic research and industry collaborations
How It Works
The success of these programs has been driven by Helix’s end-to-end platform, expertise in workflow integration and our strategic partnering approach. We provide holistic support throughout your entire implementation.
What is Sequence Once, Query OftenTM?
CDC Tier 1
Population Genomics in Action: The Healthy Nevada Project
Led by Renown Health
• A locally governed & owned, not-for-profit integrated healthcare network
• Serving 500,000 individuals
• 100,000 square mile reach
• Nevada ranked poorly (48th) when it came to overall measures of population health
• Renown wanted to utilize genetics & other data to understand key drivers of poor outcomes for the community
• Engaging the community in preventative care while reducing costs was critical to Renown’s strategy
Within one year, Renown was able to see the impact of their population genomics program and the change in the standard of care in their community.
Strong Patient Engagement
People enrolled, sequenced, and given results in the first 6 months
Of non-Renown patients had
their first visit within 6 months
Measurable Clinical Impact
1 in 75
Participants were identified as at-risk for at least one serious, actionable genetic condition
Of those patients that were found to be at-risk would not have been detected in standard clinical care
Partnering with Helix
Helix has partnered with a number of leading health systems around the nation. Learn more about how we're partnering with one organization in the video below.
Get in touch
If you have questions about your COVID-19 test result, please email email@example.com